Citation only
via OpenAlex
Diagnostic utility of IL-6 and some biomarker correlated with the diseases severity of COVID‐19 patients
Ekhlas Saddam Falih, Suhad Hassan obaid
.مجلة النسور للعلوم الطبية · 2022 · ▲ 1 citations
Abstract
Coronavirus disease 2019 (COVID-19) SARS-2 is a respiratory tract infection with a newly recognized coronavirus thought to have originated as a zoonotic virus that has mutated or otherwise adapted in ways that allow human pathogenicity. This study describe the association between IL-6, D-dimer, C-reactive protein (CRP, Ferritin, erythrocyte sedimentation rate (ESR), and hematological marker in a cohort of COVID-19 patients. The baseline characteristics of the studied samples according to age and gender with a comparison of significance in studied groups show that a total of 65 individuals were divided into three groups according to the severity of disease (17 milds, 24 moderates, and 24 severe). Moreover, no significant difference was reported in the current study according to age groups between male and female groups at P>0.05. The laboratory tests included hematological, biochemical detections, and inflammatory biomarkers. A significant increase in neutrophil counts, but decrease in lymphocyte count. While normal reading in platelet count, HB, and PCV. There were a significantly higher D-dimer and serum ferritin in the severe patient, farther increased in inflammatory marker C-reactive protein, erythrocyte sedimentation rate in moderate and sever patients (p < 0.05). Moreover, analysis of serum levels of Il-6 showed a highly significant difference in the mean value in patients groups. In Conclusion, serum IL-6 is important marker of inflammation identifying this elevated lies in the potential use of antibody against IL‐6 that can guide the clinicians in recognizing patients with severe COVID‐19 early in the disease. The potential risk factors of old age, high baseline of D-dimer, dynamic of ferritin, CRP, and ESR could help clinicians to identify and treat subjects with poor prognosis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.70492/2664-0554.1073
- Canonical
- link ↗
- Fetched
- 2026-10-15 MST
Cite this
APA
Falih, E.S., & obaid, S.H. (2022). Diagnostic utility of IL-6 and some biomarker correlated with the diseases severity of COVID‐19 patients. <em>.مجلة النسور للعلوم الطبية</em>. https://doi.org/10.70492/2664-0554.1073
Vancouver
Falih ES, obaid SH. Diagnostic utility of IL-6 and some biomarker correlated with the diseases severity of COVID‐19 patients. .مجلة النسور للعلوم الطبية. 2022. doi:10.70492/2664-0554.1073.
BibTeX
@article{ekhlas2022Diagno,
title = {Diagnostic utility of IL-6 and some biomarker correlated with the diseases severity of COVID‐19 patients},
author = {Ekhlas Saddam Falih and Suhad Hassan obaid},
journal = {.مجلة النسور للعلوم الطبية},
year = {2022},
doi = {10.70492/2664-0554.1073},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Asian Journal of Medical Sciences 2021
Open access · CC-BY
Association of inflammatory biomarkers with radiological severity for COVID-19 patient risk stratification: An Indian perspective
Reviews in Medical Virology 2020
Citation only
Immunity and inflammatory biomarkers in COVID‐19: A systematic review
Canadian Journal of Infectious Diseases and Medical Microbiology 2022
Open access · CC-BY
Elevated Salivary Inflammatory Biomarkers are Associated with SARS-CoV-2 Infection Severity
Experimental and Therapeutic Medicine 2017
Open access · CC-BY
Early diagnosis of bacterial infection in patients with septicopyemia by laboratory analysis of PCT, CRP and IL-6
American Journal of Hematology 2020
Open access · OA
Hematological findings and complications of <scp>COVID</scp>‐19
Journal of Fatima Jinnah Medical University 2022
Open access · CC-BY